创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Introduction to the main features of the in vivo tumor experimental platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-12 15:06
  • Views:

(Summary description)In the field of biomedicine, tumor research has always been an important topic for researchers. With the development of science and technology, experimental platforms are constantly upgraded to meet the needs of more accurate and faster research. The in vivo tumor experimental platform of InnoModels Biotechnology is one of the leaders, which leads the new direction of tumor research with its unique features

InnoModels Biotechnology: Introduction to the main features of the in vivo tumor experimental platform

(Summary description)In the field of biomedicine, tumor research has always been an important topic for researchers. With the development of science and technology, experimental platforms are constantly upgraded to meet the needs of more accurate and faster research. The in vivo tumor experimental platform of InnoModels Biotechnology is one of the leaders, which leads the new direction of tumor research with its unique features

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-12 15:06
  • Views:
Information

In the field of biomedicine, tumor research has always been an important topic for researchers. With the development of science and technology, experimental platforms are constantly upgraded to meet the needs of more accurate and faster research. The in vivo tumor experimental platform of InnoModels Biotechnology is one of the leaders, which leads the new direction of tumor research with its unique features.
1. Highly accurate simulation
The most important feature of InnoModels' in vivo tumor platform is its ability to simulate the complexity of tumors in the human body with a high degree of accuracy. Although traditional in vitro experiments can provide a certain amount of research data, due to the lack of complexity and dynamics of the in vivo environment, the research results are often difficult to fully reflect the real situation. By simulating the in vivo environment, the in vivo tumor experimental platform of InnoModels Biotechnology can more realistically reflect the process of tumor growth and metastasis, and provide more reliable data and results for researchers.
2. Accelerate drug development
Drug development is one of the important directions of tumor research. The traditional drug development process is often time-consuming and has a low success rate. The in vivo tumor experimental platform of InnoModels Biotechnology provides new possibilities for drug development. Researchers can utilize this platform to evaluate the effectiveness and safety of drugs more quickly, thus accelerating the drug development process. This not only improves the efficiency of drug development, but also brings earlier treatment opportunities for patients.

 


3、Support multidisciplinary research
InnoModels' in vivo tumor platform is not only suitable for basic research, but also widely used in clinical research and translational medicine. The platform supports multidisciplinary collaboration, allowing researchers to study tumors from different perspectives and at different levels. This interdisciplinary research approach helps to discover new treatment methods and approaches and promote the in-depth development of tumor research.
4、Forward-looking technology application
InnoModels Bio's in vivo tumor experimental platform adopts a series of forward-looking technology applications, such as bio-3D printing technology, biosensor technology, etc. These technologies make the experimental process more efficient. The application of these technologies makes the experimental process more precise and controllable, and at the same time provides researchers with more experimental means and data acquisition methods. The application of these technologies not only improves the experimental efficiency, but also brings new breakthroughs for tumor research.
5、Safety and ethical protection
In the process of tumor experiments, safety and ethical issues have always been of great concern. The in vivo tumor experimental platform of InnoModels Biotechnology has fully considered these issues at the beginning of its design. The platform adopts strict operational and ethical standards to ensure the safety and compliance of the experimental process. At the same time, the platform also focuses on animal welfare and ethical issues to minimize pain and harm to animals. This great attention to safety and ethics has earned the in vivo tumor experiment platform of InnoModels Biotechnology a good reputation in the industry.
6. Summary
With its highly accurate simulation, accelerated drug development, support for multidisciplinary research, and forward-looking technology application, the InnoModels Biotechnology in vivo tumor experimental platform has become an important tool in the field of tumor research. Its appearance not only improves the efficiency and accuracy of tumor research, but also provides new research ideas and methods for researchers. In the future, with the continuous progress and development of science and technology, the in vivo tumor experimental platform of InnoModels Biotechnology is expected to play a greater role in the field of tumor research and make a greater contribution to the health of mankind.

Keyword:

In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司